These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 23969981)

  • 1. Olfactory receptor 51E1 as a novel target for diagnosis in somatostatin receptor-negative lung carcinoids.
    Giandomenico V; Cui T; Grimelius L; Öberg K; Pelosi G; Tsolakis AV
    J Mol Endocrinol; 2013 Dec; 51(3):277-86. PubMed ID: 23969981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of Somatostatin Receptors 1-5 and Dopamine Receptor 2 in Lung Carcinoids: Implications for a Therapeutic Role.
    Kanakis G; Grimelius L; Spathis A; Tringidou R; Rassidakis GZ; Öberg K; Kaltsas G; Tsolakis AV
    Neuroendocrinology; 2015; 101(3):211-22. PubMed ID: 25765100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Olfactory receptor 51E1 protein as a potential novel tissue biomarker for small intestine neuroendocrine carcinomas.
    Cui T; Tsolakis AV; Li SC; Cunningham JL; Lind T; Öberg K; Giandomenico V
    Eur J Endocrinol; 2013 Feb; 168(2):253-61. PubMed ID: 23184910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the single and combined treatment with dopamine agonist, somatostatin analog and mTOR inhibitors in a human lung carcinoid cell line: an in vitro study.
    Pivonello C; Rousaki P; Negri M; Sarnataro M; Napolitano M; Marino FZ; Patalano R; De Martino MC; Sciammarella C; Faggiano A; Rocco G; Franco R; Kaltsas GA; Colao A; Pivonello R
    Endocrine; 2017 Jun; 56(3):603-620. PubMed ID: 27688013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Orthopedia homeobox is preferentially expressed in typical carcinoids of the lung.
    Hanley KZ; Dureau ZJ; Cohen C; Shin DM; Owonikoko TK; Sica GL
    Cancer Cytopathol; 2018 Apr; 126(4):236-242. PubMed ID: 29316326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Somatostatin receptor tissue distribution in lung neuroendocrine tumours: a clinicopathologic and immunohistochemical study of 218 'clinically aggressive' cases.
    Righi L; Volante M; Tavaglione V; Billè A; Daniele L; Angusti T; Inzani F; Pelosi G; Rindi G; Papotti M
    Ann Oncol; 2010 Mar; 21(3):548-555. PubMed ID: 19759190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Somatostatin and dopamine receptor expression in neuroendocrine neoplasms: correlation of immunohistochemical findings with somatostatin receptor scintigraphy visual scores.
    Diakatou E; Alexandraki KI; Tsolakis AV; Kontogeorgos G; Chatzellis E; Leonti A; Kaltsas GA
    Clin Endocrinol (Oxf); 2015 Sep; 83(3):420-8. PubMed ID: 25808161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene expression of somatostatin receptor subtypes SSTR2a, SSTR3 and SSTR5 in peripheral blood of neuroendocrine lung cancer affected patients.
    Muscarella LA; D'Alessandro V; la Torre A; Copetti M; De Cata A; Parrella P; Sperandeo M; Pellegrini F; Frusciante V; Maiello E; Merla G; Fazio VM; Vendemiale G
    Cell Oncol (Dordr); 2011 Oct; 34(5):435-41. PubMed ID: 21503779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TTF-1 expression is specific for lung primary in typical and atypical carcinoids: TTF-1-positive carcinoids are predominantly in peripheral location.
    Du EZ; Goldstraw P; Zacharias J; Tiffet O; Craig PJ; Nicholson AG; Weidner N; Yi ES
    Hum Pathol; 2004 Jul; 35(7):825-31. PubMed ID: 15257545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Somatostatin receptor subtypes in human non-functioning neuroendocrine tumors and effects of somatostatin analogue SOM230 on cell proliferation in cell line NCI-H727.
    Ono K; Suzuki T; Miki Y; Taniyama Y; Nakamura Y; Noda Y; Watanabe M; Sasano H
    Anticancer Res; 2007; 27(4B):2231-9. PubMed ID: 17695508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Somatostatin receptors in primary human breast cancer: quantitative analysis of mRNA for subtypes 1--5 and correlation with receptor protein expression and tumor pathology.
    Kumar U; Grigorakis SI; Watt HL; Sasi R; Snell L; Watson P; Chaudhari S
    Breast Cancer Res Treat; 2005 Jul; 92(2):175-86. PubMed ID: 15986128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential expression of somatostatin receptors 1-5 in neuroendocrine carcinoma of the lung.
    Tsuta K; Wistuba II; Moran CA
    Pathol Res Pract; 2012 Aug; 208(8):470-4. PubMed ID: 22770972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical utility of somatostatin receptor scintigraphic imaging (octreoscan) in esthesioneuroblastoma: a case study and survey of somatostatin receptor subtype expression.
    Rostomily RC; Elias M; Deng M; Elias P; Born DE; Muballe D; Silbergeld DL; Futran N; Weymuller EA; Mankoff DA; Eary J
    Head Neck; 2006 Apr; 28(4):305-12. PubMed ID: 16470879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatostatin Receptor Expression Is Associated With Metastasis and Patient Outcome in Pulmonary Carcinoid Tumors.
    Vesterinen T; Leijon H; Mustonen H; Remes S; Knuuttila A; Salmenkivi K; Vainio P; Arola J; Haglund C
    J Clin Endocrinol Metab; 2019 Jun; 104(6):2083-2093. PubMed ID: 30657933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current diagnosis and treatment of gastrointestinal carcinoids in a series of 101 patients: the significance of serum chromogranin-A, somatostatin receptor scintigraphy and somatostatin analogues.
    Nikou GC; Lygidakis NJ; Toubanakis C; Pavlatos S; Tseleni-Balafouta S; Giannatou E; Mallas E; Safioleas M
    Hepatogastroenterology; 2005; 52(63):731-41. PubMed ID: 15966194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ectopically expressed olfactory receptors OR51E1 and OR51E2 suppress proliferation and promote cell death in a prostate cancer cell line.
    Pronin A; Slepak V
    J Biol Chem; 2021; 296():100475. PubMed ID: 33640452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution and functional significance of somatostatin receptors in malignant melanoma.
    Lum SS; Fletcher WS; O'Dorisio MS; Nance RW; Pommier RF; Caprara M
    World J Surg; 2001 Apr; 25(4):407-12. PubMed ID: 11344389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical detection of somatostatin receptor subtypes sst1 and sst2A in human somatostatin receptor positive tumors.
    Hofland LJ; Liu Q; Van Koetsveld PM; Zuijderwijk J; Van Der Ham F; De Krijger RR; Schonbrunn A; Lamberts SW
    J Clin Endocrinol Metab; 1999 Feb; 84(2):775-80. PubMed ID: 10022452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lung Carcinoids: Long-Term Surgical Results and the Lack of Prognostic Value of Somatostatin Receptors and Other Novel Immunohistochemical Markers.
    Daskalakis K; Kaltsas G; Öberg K; Tsolakis AV
    Neuroendocrinology; 2018; 107(4):355-365. PubMed ID: 30244255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The activation of OR51E1 causes growth suppression of human prostate cancer cells.
    Maßberg D; Jovancevic N; Offermann A; Simon A; Baniahmad A; Perner S; Pungsrinont T; Luko K; Philippou S; Ubrig B; Heiland M; Weber L; Altmüller J; Becker C; Gisselmann G; Gelis L; Hatt H
    Oncotarget; 2016 Jul; 7(30):48231-48249. PubMed ID: 27374083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.